792 - Infant RSV immunoprophylaxis: A single center’s experience with early adoption of nirsevimab for all infant protection in Syracuse, New York

Holly Stacey, State University of New York Upstate Medical University, Syracuse, NY, United States; Ahmed Eltayeb, SUNY Upstate Medical University Hospital - - Syracuse, NY, syracuse, NY, United States; Kevin B. Hu, State University of New York Upstate Medical University, Syracuse, NY, United States; John J. Alfarone, State University of New York Upstate Medical University, Syracuse, NY, United States; Cara Smith, State University of New York Upstate Medical University, Syracuse, NY, United States; Ava Conklin, State University of New York Upstate Medical University, Syracuse, NY, United States; Steven Blatt, SUNY Upstate Medical, Syracuse, NY, United States; Joseph Domachowske, Upstate Golisano Children's Hospital, Syracuse, NY, United States; Danielle K. Daniels, Upstate Golisano Children's Hospital, Pennellville, NY, United States